Goodbody Health Inc. announced revenue results for the first two months of 2022. Even with the expected drop off from PCR testing in 2022, the Company generated revenue, in the first two months of 2022 to the end of February, of over CAD 6 million showing that first quarter is still performing well.
Goodbody Health Canadian Securities Exchange
Equities
SWEL
CA3821591011
Pharmaceuticals
1st Jan change | Capi. | |
---|---|---|
+42.64% | 6.38B | |
-15.52% | 4.59B | |
+8.35% | 3.39B | |
-11.10% | 3.2B | |
-4.12% | 2.52B | |
+46.46% | 2B | |
-7.97% | 1.7B | |
-1.07% | 1.65B | |
-11.56% | 1.58B |